Mills Ch35 Prostate

980

SECTION IX : GenitourinaryTract

10. McNeal JE. Normal histology of the prostate. Am J Surg Pathol 1988;12(8):619–633. 11. Wheeler TM. Anatomic considerations in carcinoma of the prostate. Urol Clin North Am 1989;16:623–634. 12. McNeal JE, Bostwick DG, Kindrachuk RA, et al. Patterns of progression in prostate cancer. Lancet 1986;1:60–63. 13. Partin AW, Epstein JI, Cho KR, et al. Morphometric measure- ment of tumor volume and percent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol 1989;141:341–345. 14. Fine SW, Al-Ahmadie HA, GopalanA, et al. Anatomy of the ante- rior prostate and extraprostatic space: A contemporary surgical pathology analysis. Adv Anat Pathol 2007;14:401–407. 15. Myers RP, Goellner JR, Cahill DR. Prostate shape, external striated urethral sphincter and radical prostatectomy: The apical dissection. J Urol 1987;138:543–550. 16. McNeal JE. The zonal anatomy of the prostate. Prostate 1981;2:35–49. 17. Gagukas RJ, Brown RW, Wheeler TM. Verumontanum muco- sal gland hyperplasia. Am J Surg Pathol 1995;19:30–36. 18. Greene DR, Wheeler TM, Egawa S, et al. Relationship between clinical stage and histological zone of origin in early prostate cancer: Morphometric analysis. Br J Urol 1991;68:499–509. 19. Ayala AG, Ro JY, Babaian R, et al. The prostatic capsule: Does it exist? Its importance in the staging and treatment of prostatic carcinoma. Am J Surg Pathol 1989;13:21–27. 20. McNeal JE, Villers AA, Redwine EA, et al. Capsular penetra- tion in prostate cancer: Significance for natural history and treatment. Am J Surg Pathol 1990;14:240–247. 21. McNeal JE, Redwine EA, Freiha FS, et al. Zonal distribution of prostatic adenocarcinoma: Correlation with histologic patterns and direction of spread. Am J Surg Pathol 1988;12:897–906. 22. Walsh PC. Radical retropubic prostatectomy with reduced morbidity: An anatomic approach. NCI Monogr 1988;7: 133–137. 23. Tanagho EA, Smith DR. The anatomy and function of the bladder neck. Br J Urol 1966;38:54–71. 24. Villers A, McNeal JE, Freiha FS, et al. Invasion of Denon- villiers’ fascia in radical prostatectomy specimens. J Urol 1993;149:793–798. 25. Lepor H, Gregerman M, Crosby R, et al. Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa: A detailed anatomical study of the adult male pelvis. J Urol 1985;133:207–212. 26. Villers A, McNeal JE, Redwine EA, et al. The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol 1989;142:763–768. 27. Ostrowski ML, Wheeler TM. Paraganglia of the prostate. Location, frequency, and differentiation from prostatic ade- nocarcinoma. Am J Surg Pathol 1994;18:412–420. 28. Catalona WJ, Dresner SM. Nerve-sparing radical prosta- tectomy: Extraprostatic tumor extension and preservation of erectile function. J Urol 1985;134:1149–1151. 29. Eggleston JC, Walsh PC. Radical prostatectomy with pres- ervation of sexual function: Pathological findings in the first 100 cases. J Urol 1985;134:1146–1148.

30. Flocks RH. The arterial distribution within the prostate gland: its role in transurethral prostatic resection. J Urol 1937;37: 524–525. 31. Clegg EV. The vascular arrangements within the human prostate gland. Br J Urol 1956;28:428–435. 32. McNeal JE. Age-related changes in the prostatic epithelium associated with carcinoma. In: Griffiths K, Pierrepoint CG, eds. Some Aspects of the Aetiology and Biochemistry of Prostatic Cancer . Cardiff, Wales: Tenovus; 1970:23–32. 33. McNeal JE. Aging and the prostate. In: Brocklehurst JC, ed. Urology in the Elderly . Edinburgh: Churchill Livingstone; 1984:193–202. 34. Mao P, Angrist A. The fine structure of the basal cell of human prostate. Lab Invest 1966;15:1768–1782. 35. Brawer MK, Peehl DM, Stamey TA, et al. Keratin immunore- activity in the benign and neoplastic human prostate. Cancer Res 1985;45:3663–3667. 36. Hedrick L, Epstein JI. Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma. Am J Surg Pathol 1989;13: 389–396. 37. Weinstein MH, Signoretti S, Loda M. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Mod Pathol 2002;15:1302–1308. 38. di Sant’Agnese PA. Neuroendocrine differentiation in pros- tatic carcinoma. Cancer 1995;75:1850–1859. 39. Reese JH, McNeal JE, Redwine EA, et al. Differential dis- tribution of pepsinogen II between the zones of the human prostate and the seminal vesicle. J Urol 1986;136:1148–1152. 40. Reese JH, McNeal JE, Redwine EA, et al. Tissue type plas- minogen activator as a marker for functional zones, within the human prostate gland. Prostate 1988;12:47–53. 41. Gelmann EP, Bowen C, Bubendorf L. Expression of NKX3.1 in normal and malignant tissues. Prostate 2003;55:111–117. 42. deVries CR, McNeal JE, Bensch K. The prostatic epithe- lial cell in dysplasia: An ultrastructural perspective. Prostate 1992;21:209–221. 43. De Marzo AM, Platz EA, Epstein JI, et al. A working group classification of focal prostate atrophy lesions. Am J Surg Pathol 2006;30:1281–1291. 44. Price H, McNeal JE, Stamey TA. Evolving patterns of tissue composition in benign prostatic hyperplasia as a function of specimen size. Hum Pathol 1990;21:578–585. 45. Cleary KR, Choi HY, Ayala AG. Basal cell hyperplasia of the prostate. Am J Clin Pathol 1983;80:850–854. 46. Milord RA, Kahane H, Epstein JI. Infarct of the prostate gland: Experience on needle biopsy specimens. Am J Surg Pathol 2000;24:1378–1384. 47. Wobker SE, Khararjian A, Epstein JI. GATA3 positivity in benign radiated prostate glands: A potential diagnostic pitfall. Am J Surg Pathol 2017;41:557–563. 48. Tian W, Dorn D, Wei S, et al. GATA3 expression in benign glands with radiation atypia: A diagnostic pitfall. Histopathol 2017;71:150–155. 49. Haarer CF, Gopalan A, Tickoo SK, et al. Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors. J Urol 2009;182:1337–1341.